RADx Tech ACT ENDO Announcement - CIMIT MAIN
Cimit News
Rapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge
Endometriosis is a chronic inflammatory condition characterized by the growth of uterine endometrium-like tissue outside the uterus; the often-debilitating condition affects approximately 1 in 10 reproductive-aged women worldwide. Novel approaches are urgently needed to identify those who are afflicted with the condition and to spur the development of new treatments and cures.
The Rapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge will award $3.0 million in prizes to accelerate the development of innovative technologies for the diagnosis of endometriosis.